-
公开(公告)号:US20170158693A1
公开(公告)日:2017-06-08
申请号:US15435553
申请日:2017-02-17
发明人: Gisela BACKFISCH , Margaretha Henrica Maria BAKKER , Günter BLAICH , Wilfried BRAJE , Karla DRESCHER , Thomas ERHARD , Andreas HAUPT , Hannes KOOLMAN , Viktor LAKICS , Anna LINSENMEIER , Helmut MACK , Raimund PETER , Ana Lucia RELO , Xiaona ZHAO , Jincheng WANG
IPC分类号: C07D471/06
CPC分类号: C07D471/06 , C07D471/04
摘要: The present invention relates to tricyclic hexahydrodiazepinoquinolines carrying a cyclic substituent, to a method for producing them, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor, and processes for preparing such compounds and compositions.
-
公开(公告)号:US20190062305A1
公开(公告)日:2019-02-28
申请号:US15761735
申请日:2016-09-21
发明人: Gisela BACKFISCH , Margaretha BAKKER , Günter BLAICH , Wilfried BRAJE , Karla DRESCHER , Thomas ERHARD , Andreas HAUPT , Carolin HOFT , Andreas KLING , Viktor LAKICS , Helmut MACK , Frank OELLIEN , Raimund PETER , Frauke POHLKI , Ana Lucia RELO
IPC分类号: C07D401/12 , C07D401/14
摘要: The present invention relates to pyridyl or pyrazinyl compounds carrying a methyl-bound N-amide moiety derived from an α-amino acid of formula I where the variables are as defined in the claims and the description. The invention further relates to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, and to their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of the 5-HT2C receptor.
-
公开(公告)号:US20170112851A1
公开(公告)日:2017-04-27
申请号:US15397902
申请日:2017-01-04
发明人: Gisela BACKFISCH , Margaretha Henrica Maria BAKKER , Günter BLAICH , Wilfried BRAJE , Karla DRESCHER , Thomas ERHARD , Andreas HAUPT , Viktor LAKICS , Anna LINSENMEIER , Helmut MACK , Raimund PETER , Ana Lucia RELO , Lynette SMITH
IPC分类号: A61K31/5513
CPC分类号: A61K31/5513 , C07D471/04 , C07D471/18
摘要: The present invention relates to tricyclic hexahydrodiazepinoquinolines carrying a substituted alkyl radical, to a method for producing them, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor, and processes for preparing such compounds and compositions.
-
公开(公告)号:US20180339996A1
公开(公告)日:2018-11-29
申请号:US15778597
申请日:2016-11-24
发明人: Gisela BACKFISCH , Margaretha Henrica Maria BAKKER , Günter BLAICH , Wilfried BRAJE , Karla DRESCHER , Thomas ERHARD , Andreas HAUPT , Carolin HOFT , Viktor LAKICS , Helmut MACK , Frank OELLIEN , Raimund PETER , Ana Lucia RELO
IPC分类号: C07D498/04 , C07D498/14
摘要: The present invention relates to compound of formula (I) (I) wherein the variables are as defined in the claims and the description. The invention further relates to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, to their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, and to methods for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor.
-
5.
公开(公告)号:US20150259346A1
公开(公告)日:2015-09-17
申请号:US14657916
申请日:2015-03-13
发明人: Gisela BACKFISCH , Margaretha Henrica Maria BAKKER , Günter BLAICH , Wilfried BRAJE , Karla DRESCHER , Thomas ERHARD , Andreas HAUPT , Viktor LAKICS , Anna LINSENMEIER , Helmut MACK , Raimund PETER , Ana Lucia RELO , Lynette SMYTH
IPC分类号: C07D471/18
CPC分类号: A61K31/5513 , C07D471/04 , C07D471/18
摘要: The present invention relates to tricyclic hexahydrodiazepinoquinolines carrying a substituted alkyl radical, to a method for producing them, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor, and processes for preparing such compounds and compositions.
摘要翻译: 本发明涉及携带取代烷基的三环六氢二氮杂喹啉,其制备方法,含有这些化合物的药物组合物,其用作5-HT 2C受体的调节剂,特别是激动剂或部分激动剂,其用途 制备用于预防或治疗对5-HT 2C受体的调节作出反应的病症和障碍的药物,用于预防或治疗对5-HT 2C受体的调节作出反应的病症和障碍的方法,以及制备这种化合物的方法 和组合物。
-
公开(公告)号:US20150259343A1
公开(公告)日:2015-09-17
申请号:US14657840
申请日:2015-03-13
发明人: Gisela BACKFISCH , Margaretha Henrica Maria BAKKER , Günter BLAICH , Wilfried BRAJE , Karla DRESCHER , Thomas ERHARD , Andreas HAUPT , Hannes KOOLMAN , Viktor LAKICS , Anna LINSENMEIER , Helmut MACK , Raimund PETER , Ana Lucia RELO
IPC分类号: C07D471/06
CPC分类号: C07D471/06 , C07D471/04
摘要: The present invention relates to tricyclic hexahydrodiazepinoquinolines carrying a cyclic substituent, to a method for producing them, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor, and processes for preparing such compounds and compositions.
摘要翻译: 本发明涉及携带环状取代基的三环六氢二氮杂喹啉,其制备方法,含有这些化合物的药物组合物,其用作5-HT 2C受体的调节剂,特别是激动剂或部分激动剂,其用于制备 用于预防或治疗对5-HT 2C受体的调节作出反应的病症和障碍的药物,用于预防或治疗对5-HT 2C受体调节作用的病症和障碍的方法,以及制备这种化合物的方法和 组合物。
-
-
-
-
-